EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Respiratory performance in Duchenne muscular dystrophy: Clinical manifestations and lessons from animal models

Rebecca Delaney, Ken D O'Halloran iD

Experimental Physiology · 2024

DOI: 10.1113/ep091967 ↗

At a glance

Übersichtsarbeit in Experimental Physiology, 2024. Written by Rebecca Delaney and 1 co-authors. Institution: Department of Physiology, University College Cork, Cork, Ireland. Major MEDLINE topics: Muscular Dystrophy, Duchenne, Disease Models, Animal. Cited 4 times so far (Crossref); 125 references. The full text is freely available (open access, CC BY 4.0). Funded by: Science Foundation Ireland (SFI).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Duchenne muscular dystrophy (DMD) is a fatal genetic neuromuscular disease. Lack of dystrophin in skeletal muscles leads to intrinsic weakness, injury, subsequent degeneration and fibrosis, decreasing contractile function. Dystropathology eventually presents in all inspiratory and expiratory muscles of breathing, severely curtailing their critical function. In people with DMD, premature death is caused by respiratory or cardiac failure. There is an urgent need to develop therapies that improve quality of life and extend life expectancy in DMD. Surprisingly, there is a dearth of information on respiratory control in animal models of DMD, and respiratory outcome measures are often limited or absent in clinical trials. Characterization of respiratory performance in murine and canine models has revealed extensive remodelling of the diaphragm, the major muscle of inspiration. However, significant compensation by extradiaphragmatic muscles of breathing is evident in early disease, contributing to preservation of peak respiratory system performance. Loss of compensation afforded by accessory muscles in advanced disease is ultimately associated with compromised respiratory performance. A new and potentially more translatable murine model of DMD, the D2 .mdx mouse, has recently been developed. Respiratory performance in D2 .mdx mice is yet to be characterized fully. However, based on histopathological features, D2 .mdx mice might serve as useful preclinical models, facilitating the testing of new therapeutics that rescue respiratory function. This review summarizes the pathophysiological mechanisms associated with DMD both in humans and in animal models, with a focus on breathing. We consider the translational value of each model to human DMD and highlight the urgent need for comprehensive characterization of breathing in representative preclinical models to better inform human trials.

Subjects

MeSH terms (MEDLINE)

Muscular Dystrophy, DuchenneDisease Models, AnimalAnimalsHumansMiceMice, Inbred mdxDogsDiaphragmRespiratory MusclesRespirationMuscle, Skeletal

Author keywords

D2.mdx miceDuchenne muscular dystrophycontrol of breathingmdx micepeak inspiratory pressure

Authors and institutions

  • Department of Physiology, University College Cork, Cork, Ireland.

ORCID profiles: Ken D O'Halloran

Funding

  • Science Foundation Ireland (SFI)

Cite

APA

Delaney, R., & O'Halloran, K. D. (2024). Respiratory performance in Duchenne muscular dystrophy: Clinical manifestations and lessons from animal models. Experimental Physiology. https://doi.org/10.1113/ep091967

Vancouver

Delaney R, O'Halloran KD. Respiratory performance in Duchenne muscular dystrophy: Clinical manifestations and lessons from animal models. Experimental Physiology. 2024. doi:10.1113/ep091967

BibTeX
@article{Delaney2024,
  author = {Delaney, Rebecca and O'Halloran, Ken D},
  title = {Respiratory performance in Duchenne muscular dystrophy: Clinical manifestations and lessons from animal models},
  journal = {Experimental Physiology},
  year = {2024},
  doi = {10.1113/ep091967}
}
Start for free →